OMCM On Other Exchanges
Symbol
Exchange
OTC US

omnicomm systems inc (OMCM) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OMNICOMM SYSTEMS INC (OMCM)
\

Related News

No related news articles were found.

omnicomm systems inc (OMCM) Related Businessweek News

No Related Businessweek News Found

omnicomm systems inc (OMCM) Details

OmniComm Systems, Inc. operates as a healthcare technology company worldwide. The company engages in the provision of Web-based electronic data capture (EDC) and eClinical software and services for pharmaceutical and biotechnology companies, clinical research organizations (CROs), and other clinical trial sponsors. It offers TrialMaster, which allows organizations conducting clinical trials to collect and manage the data over the Internet; TrialOne Phase I Clinic Automation, a software application suite that provides clinical trial site sponsors, study investigators, and study monitors with various tools designed to make the overall Phase I clinic operation; and IRTMaster, which offers interactive response technology in support of the randomization process in clinical trials. The company also provides eClinical Suite that comprises a set of tools for collecting and managing clinical data, including EDC for real-time entry and double data entry (DDE) for entry from paper originals; and Promasys, a clinical trial data management system for DDE and EDC, which is primarily used at research institutions for investigator-initiated trials. In addition, it offers consulting and professional services, such as project management, clinical services, training, custom configuration, system integration, standard operating procedures and implementation assistance, installation, and validation services, as well as application hosting and support services. The company sells its products through its direct sales force and relationships with CRO partners, as well as through co-marketing agreements with vendor and channel partners. OmniComm Systems, Inc. was founded in 1996 and is headquartered in Fort Lauderdale, Florida.

175 Employees
Last Reported Date: 05/15/19
Founded in 1996

omnicomm systems inc (OMCM) Top Compensated Officers

President & CEO
Total Annual Compensation: $352.2K
Executive Chairman
Total Annual Compensation: $18.0K
Founder & Executive Vice Chairman
Total Annual Compensation: --
Chief Commercial Officer
Total Annual Compensation: $461.6K
Compensation as of Fiscal Year 2018.
omnicomm systems inc
Omnicomm Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019

OmniComm Systems, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was USD 5.715 million compared to USD 7.190 million a year ago. Operating loss was USD 397,778 compared to operating Income of USD 905,136 a year ago. Net loss was USD 1.266 million compared to net income of USD 593,483 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to Basic EPS - Continuing Operations of USD 0 a year ago.

Strong Growth Globally in Academic Medical Center Contracts for OmniComm Systems

OmniComm Systems, Inc. continues to expand its global footprint in the research hospital and academic medical center (AMC) sector. The contract value of agreements for OmniComm’s eClinical solutions and services for 2018 was more than twice the total volume for 2017 in the AMC sector. Leading academic centers from Europe, Asia and the U.S. have recently signed agreements for a variety of electronic data capture (EDC) and eClinical products, and related professional services from OmniComm Systems. During 2018, OmniComm signed landmark contracts to provide TrialMaster and TrialOne® to several major contract research organizations (CROs) and hospitals in China and Japan. For example, Guangzhou Boji, a publicly traded company in China that partners with several hospitals, sought an EDC system that could meet its high-quality standards and offer efficiency during early-phase clinical research. Guangzhou Boji selected TrialOne based on total evaluation scores and TrialOne’s compliance with GCP regulations. Likewise, in the U.S., a leading research hospital with a global network selected OmniComm’s TrialMaster to implement a comprehensive set of solutions for EDC, IRT, clinical trial management systems (CTMS), clinical reporting and overall process improvement. The institution also sought and succeeded in integrating TrialMaster EDC with its EHR system to expedite and simplify data capture. Throughout Asia, Europe and North America, OmniComm’s TrialMaster EDC, TrialOne and professional services have been selected by academic and medical institutions because of their inherent flexibility, scalability, data quality and broad capabilities to provide a highly configurable, integrated EDC solution. OmniComm’s expertise in integrating electronic medical record (EMR) systems and CTMS with TrialMaster EDC has been an important factor in recent selection decisions.

Rundo International Pharmaceutical Research & Development Co., Ltd. Selects eClinical Solutions from OmniComm Systems, Inc

Rundo International Pharmaceutical Research & Development Co. Ltd. has selected eClinical solutions from OmniComm Systems, Inc. Under the terms of two separate agreements, Rundo will use OmniComm’s TrialMaster EDC and TrialOne for research. Rundo’s customers in China include domestic and multinational companies, with research ranging from Phase I through IV clinical trials. After comprehensive evaluations, Rundo selected OmniComm’s eClinical solutions for multiple reasons, including the availability of mature and validated systems, multiple therapeutic areas of experience, support of industry standards and competitive pricing. Additionally, OmniComm’s eClinical solutions provide market-leading technology for early phase research and Phase II-IV studies. As a system that is compliant with global industry standards, TrialMaster allows user organizations to ensure the quality and integrity of data collected and managed during an entire set of studies. TrialMaster also enables users to comply with China’s FDA (NMPA) regulations and approval process for new drugs, and comply with regulations from the U.S. FDA and the EMA. TrialOne reduces timelines and costs through faster and more directed volunteer recruitment, easy-to-build schedule-based workflows, real-time Bedside Data Collection (BDC), direct data capture from devices, and automated processing of laboratory samples.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

OMCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OMCM.
View Industry Companies
 

Industry Analysis

OMCM

Industry Average

Valuation OMCM Industry Range
Price/Earnings 24.9x
Price/Sales 1.8x
Price/Book NM Not Meaningful
Price/Cash Flow 16.6x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OMNICOMM SYSTEMS INC, please visit www.omnicomm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.